Receptor activity-modifying proteins of adrenomedullin (RAMP2/3): Roles in the pathogenesis of ARDS.
Tomoki Kasahara,Megumu Tanaka,Yunlu Zhao,Akiko Kamiyoshi,Takayuki Sakurai,Yuka Ichikawa-Shindo,Hisaka Kawate,Yorishige Matsuda,Yan Zhang,Qianqian Guo,Peixuan Li,Ken Hoshiyama,Jiake Li,Naho Onishi,Marina Hayashi,Hideki Sanjo,Kumiko Ishida,Satoshi Tanaka,Mikito Kawamata,Takayuki Shindo
DOI: https://doi.org/10.1016/j.peptides.2023.171118
IF: 3.867
2023-11-27
Peptides
Abstract:Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition characterized by widespread inflammation and pulmonary edema. Adrenomedullin (AM), a bioactive peptide with various functions, is expected to be applied in treating ARDS. Its functions are regulated primarily by two receptor-activity-modifying proteins, RAMP2 and RAMP3, which bind to the AM receptor calcitonin-receptor-like receptor (CLR). However, the roles of RAMP2 and RAMP3 in ARDS remain unclear. We generated a mouse model of ARDS via intratracheal administration of lipopolysaccharide (LPS), and analyzed the pathophysiological significance of RAMP2 and RAMP3. RAMP2 expression declined with LPS administration, whereas RAMP3 expression increased at low doses and decreased at high doses of LPS. After LPS administration, drug-inducible vascular endothelial-cell-specific RAMP2 knockout mice (DI-E-RAMP2 −/− ) showed reduced survival, increased lung weight, and had more apoptotic cells in the lungs. DI-E-RAMP2 −/− mice exhibited reduced expression of Epac1 (which regulates vascular endothelial cell barrier function), while RAMP3 was upregulated in compensation. In contrast, after LPS administration, RAMP3 −/− mice showed no significant changes in survival, lung weight, or lung pathology, although they exhibited significant downregulation of iNOS, TNF-α, and NLRP3 during the later stages of inflammation. Based on transcriptomic analysis, RAMP2 contributed more to the circulation-regulating effects of AM, whereas RAMP3 contributed more to its inflammation-regulating effects. These findings indicate that, while both RAMP2 and RAMP3 participate in ARDS pathogenesis, their functions differ distinctly. Further elucidation of the pathophysiological significance and functional differences between RAMP2 and RAMP3 is critical for the future therapeutic application of AM in ARDS.
pharmacology & pharmacy,biochemistry & molecular biology,endocrinology & metabolism